Top Markets
Coin of the day
Agile Therapeutics, Inc. Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

AGRX
Pozycja w akcjach #38231
Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated... Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.
Cena akcji
$1.51
Ostatnia synchronizacja: 2024-08-26
Kapitalizacja rynkowa
$1.12M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Agile Therapeutics, Inc. (AGRX)

Kategoria

Wskaźnik P/B dla Agile Therapeutics, Inc. (AGRX)
Wskaźnik P/B na dzień August 2026 TTM: -0.20
Według najnowszych raportów finansowych i ceny akcji Agile Therapeutics, Inc., obecny wskaźnik P/B (TTM) wynosi -0.20. Na koniec 2022 wynosił -0.88.
Historia wskaźnika P/B dla Agile Therapeutics, Inc. od 2012 do 2026
Wskaźnik P/B na koniec każdego roku
Rok Wskaźnik P/B Zmień
2026 (TTM) -0.20 -23.23%
2023 -0.26 -70.87%
2022 -0.88 -792.80%
2021 0.13 -97.41%
2020 4.93 82.38%
2019 2.70 175.75%
2018 0.98 -57.24%
2017 2.29 -39.87%
2016 3.81 -47.25%
2015 7.22 271.82%
2014 1.94 -377.53%
2013 -0.70 -17.96%
2012 -0.85 0.00%
Wskaźnik P/B dla podobnych firm lub konkurentów